Integer Holdings Corporation (NYSE:ITGR) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR - Get Free Report) have been given an average rating of "Buy" by the nine analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $145.00.

A number of equities research analysts recently issued reports on ITGR shares. Truist Financial set a $150.00 price target on Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and lifted their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. KeyCorp reduced their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Finally, Raymond James Financial lifted their price objective on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, April 25th.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director now owns 22,170 shares of the company's stock, valued at $2,672,815.20. This trade represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is currently owned by insiders.

Institutional Trading of Integer

Large investors have recently made changes to their positions in the company. Principal Financial Group Inc. boosted its holdings in Integer by 3.9% in the fourth quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock valued at $24,154,000 after purchasing an additional 6,905 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Integer in the 4th quarter valued at $208,000. Intech Investment Management LLC grew its position in shares of Integer by 51.1% in the 4th quarter. Intech Investment Management LLC now owns 11,767 shares of the medical equipment provider's stock valued at $1,559,000 after buying an additional 3,980 shares during the last quarter. HighTower Advisors LLC raised its stake in Integer by 1.4% during the 4th quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider's stock worth $1,618,000 after acquiring an additional 166 shares in the last quarter. Finally, Cibc World Markets Corp purchased a new stake in Integer in the fourth quarter valued at $413,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Performance

NYSE:ITGR opened at $118.86 on Friday. The stock has a 50-day moving average price of $119.87 and a 200 day moving average price of $126.94. The stock has a market capitalization of $4.15 billion, a P/E ratio of 56.33, a P/E/G ratio of 1.02 and a beta of 0.98. Integer has a 12-month low of $104.93 and a 12-month high of $146.36. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The business had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the prior year, the firm earned $1.14 EPS. The business's revenue was up 7.3% on a year-over-year basis. Equities research analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.